Search Results 711-720 of 19760 for Receptor
Updated results from a phase 1 study (CRB-401) of idecabtagene vicleucel (ide-cel, bb2121), an anti-B cell maturation antigen (BCMA) chimeric antigen receptor ...
Treatment · Treatments to control hormones made by the tumor · Surgery · Radiation therapy · Ablation therapy · Chemotherapy · Targeted therapy · Peptide receptor ...
... receptor (EGFR) and/or human epidermal growth factor receptor (HER2) mutations. The study drug, BH-30643 capsules, will be self-administered by mouth twice ...
... Receptor-Positive, HER2-Positive Breast Cancer. J Natl Compr Canc Netw. 2024 Aug 26; 22 (7):463-468. View PubMed; Díaz-Cortés H, Hedges MS, Pacheco-Spann LM ...
Developing chimeric antigen receptor (CAR)‑macrophage and CAR‑T cell therapies to function effectively within hostile metastatic niches. Examining how ...
A class of medications known as selective estrogen receptor modulators can also be used to lessen your risk of breast cancer recurrence. These medications ...
Specifically, the research focused on three proteins often found in aggressive cancers. These include human epidermal growth factor receptor 2 (HER2), epidermal ...
GLP-1 receptor agonists as pharmacological treatment for obesity after spinal cord injury: clinical considerations. Arch Phys Med Rehabil. 2026 Mar 11 [Epub ...
Patients with IHA should be treated not surgically but medically with a mineralocorticoid receptor antagonist. Therefore, determining the subtype of PA (APA ...
This expanded access therapeutic protocol aims to allow patients suffering from inoperable, somatostatin receptor positive, neuroendocrine tumors ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.